Welcome to our new site!

We have updated our website to make it easier for you to place and track orders, refill your prescriptions, and view your account information. If you are already a customer, you will now be able to access your account directly. We have also enhanced our security to ensure the protection of your information.

You will soon receive an email with a Username and Password that you can use to log in to your account. Be sure to check your spam folder for this email. If you do not receive this email, or if you have trouble logging into your account, please contact us toll-free at 1-844-560-7790.

You can easily register a free account by clicking here. If you have any trouble, please call us at 1-844-560-7790.

We apologize for any inconvenience or issues you may experience as we continue adjusting our new website. We hope you will enjoy our updates and continue saving on your brand insulin!

Learn how to order on our new site by clicking here.

Contact us
Customer Service Hours
Mon-Fri 9AM to 6:30PM EST
Email service@canadianinsulin.com
Phone 1-844-560-7790
Fax 1-866-951-0118

Inhaled Insulin Brands for Diabetes Mellitus

Inhaled Insulin Brands for Diabetes Mellitus

Diabetic symptoms usually develop due to a lack of insulin, a type of hormone that helps to regulate the blood sugar level. Produced by the Eli Lilly and Company in 1982, an insulin injection was the first genetically-engineered pharmaceutical product approved for diabetes treatment. While injectable insulin is highly effective in managing diabetes mellitus, a lot of patients are terrified of needles. Plus, having to self-inject on a daily basis can be a major inconvenience for many diabetic patients. For many years, scientists have been working on alternative forms of insulin. While insulin pills have yet to be successfully formulated, patients now have the option to inhale insulin instead of injecting it. The idea of inhaled insulin is nothing new, however, it wasn’t until the 90s that it is made possible. Similar to asthma inhalers, the insulin inhaler is able to dispense a fine insulin powder into the lungs. Once inhaled, the insulin can enter through blood vessels.

Indicated for patients who have type I or type II diabetes, Exubera was the first FDA-approved inhaled insulin brand. However, one year after its launch, Exubera was withdrawn from the market by its manufacturer. Being awkwardly large and bulky, it failed to gain popularity among diabetic patients. The FDA also expressed concerns that the insulin inhaler might result in lung diseases (including cancer).

Afrezza is another brand of inhaler that contains pre-measured, rapid-acting insulin. Approved in 2014, the inhaled insulin is designed to be used before meals. Similar to Exubera, Afrezza is indicated for the treatment of type I and type II diabetes (but, thankfully, it comes in a much smaller size). When used in the treatment of type I diabetes, patients will still need to use a long-acting insulin for consistent blood glucose control throughout the day. Keep in mind that the inhaled insulin is not meant for diabetic emergencies, e.g. diabetic ketoacidosis (DKA). Afrezza is associated with common adverse reactions such as sore throat, scratchy throat, coughing, and hypoglycemia (low blood sugar). In general, inhaled insulin should not be used in patients who are smoking and those who have a lung disease.

Reset Your Password

Please enter your Username below and we will send a new password to the email associated with your account. Check your spam folder if you do not receive your new password.

Still having trouble logging in?

If you’re unable to log in, please call our customer service at 1-844-560-7790.